Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

7

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1992

4

2007

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

4

Acne

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Inactive ingredient

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

7

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

7

FDA UNII

7

PUBCHEM

7

EPA CompTox

6

ECHA (EC/EINECS)

5

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

5

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 7 of 7 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

SEBACIC ACID

97AN39ICTC

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

ADIPIC ACID

76A0JE0FKJ

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

DISODIUM SEBACATE

J3YU3MBH4Z

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

SEBACATE DIANION

PYO1TT7HG2

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

ADIPATE ION

U3YC62H084

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

DIAMMONIUM ADIPATE

9VH76YE3HU

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

SODIUM ADIPATE

3XG6T5KYKM

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1